FDA Grants Accelerated Approval For Breast Cancer Drug

FDA Grants Accelerated Approval For Breast Cancer Drug Camizestrant's approval as a first-line treatment goes against recommendations from the agency's outside experts. Also in the news, new immunotherapy results for some cancers; AI-generated drugs for lung disease; and more. https://kffhealthnews.org/morning-breakout/pharma-and-tech-090926/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsenc=p2ANqtz-_PbhjRsNdObNKO4cT2AXDv5D71gjwG8NeBlcoIYBYLimk4u4LJnjdsv_dX1SQYR2xRAbGZfH5TxvYkufrmOlfACOQTEg&_hsmi=438136616&utm_content=438136616&utm_source=hs_email